# A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions

> **NCT02052752** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 90 (actual)

## Conditions studied

- Skin Diseases

## Interventions

- **DRUG:** 3% Benzoyl Peroxide
- **DRUG:** 3% Benzoyl Peroxide Placebo
- **DRUG:** Neutrogena Rapid Clear®

## Key facts

- **NCT ID:** NCT02052752
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2015-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052752, "A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02052752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*